New hope for diabetes treatment

New York- The researchers suggested the development of a badtail of drugs that would help make insulin-producing cells more distinctive, which could lead to the treatment of diabetes.

Diabetics suffer from a lack of beta cells, which produce insulin, which transfers food sugar to the body's cells to be used in the energy body, and that without enough, it can not produce "glucose" correctly for diabetics, according to the British "Daily Mail" newspaper.

A team of researchers at Mount Sinai Hospital for Diabetes and Metabolism in New York discovered that a drug called hardin could activate pancreatic cells to produce beta cells that are ten times more productive. insulin.

They also discovered that when "hardin" is mixed with another drug – commonly used to promote bone growth – beta cells form more than 40 times a day.

Hardin alone produces 2% insulin a day, but when it is administered with the other drug, it reaches 5 to 8% per day.

The new drug is still in the experimental stage and is in the early stages of testing, but researchers believe that its powerful effect on insulin-producing cells could be a way to change the rules of the game in the treatment of diabetes-type I and type II.

"We are very excited about this discovery," said Dr. Stewart, of the Mount Sinai School of Medicine. "We have discovered a drug structure that allows beta cells to regenerate at an appropriate rate of treatment, but this new therapeutic approach has only been tested on rodents in the laboratory, before treatment is experienced in the past." 39, where researchers need to develop a targeted delivery system. "

Stewart also pointed out that one of the challenges of the new drug badtail is that it has effects on other members, although this has not been determined.